Core Viewpoint - Mousse Health Sleep Co., Ltd. has signed a memorandum of cooperation with Huawei to integrate its health sleep system with the HarmonyOS ecosystem, aiming to create a unified smart sleep environment that enhances user experience through system-level integration rather than fragmented operations [1][2]. Group 1: Partnership Details - The memorandum outlines that Mousse will connect its health sleep system to the HarmonyOS, allowing its AI smart mattress to interact with other smart devices in the bedroom, such as lights, curtains, and air conditioning [1]. - The collaboration aims to establish a "full-scene smart sleep ecosystem" where different brands and types of bedroom devices can work together under Mousse's sleep system, reducing the need for users to operate each device individually at night [1][2]. Group 2: Technical Integration - The integration process involves the AI smart mattress reading pressure data and synchronizing it with other devices in the bedroom through HarmonyOS's distributed capabilities, enabling automated adjustments like dimming lights and closing curtains without manual intervention [2]. - The memorandum also emphasizes "technical standardization," where Mousse's sleep technology algorithms and Harmony's interconnection protocols will be used to create interface standards that can be shared with the industry, potentially reducing redundant development and promoting a unified interconnection protocol in the health sleep industry [2]. Group 3: Strategic Implications - For Mousse, this partnership represents an expansion of its product matrix and a shift towards offering personalized, intelligent health sleep solutions rather than just selling mattresses [3]. - For HarmonyOS, the deep integration of bedroom scenarios will strengthen its system-level advantages in the whole-home smart field, providing a model for collaboration between home manufacturing companies and digital platforms in the context of differentiated terminal demands and the lack of industry standards [3].

Core Viewpoint - The company has approved a share buyback plan to reduce registered capital by repurchasing shares using its own funds, with a total buyback amount ranging from RMB 120 million to RMB 240 million [2][3]. Buyback Plan Details - The buyback will be conducted through the Shenzhen Stock Exchange, targeting A-shares, with a maximum repurchase price set at RMB 39 per share initially, later adjusted to RMB 38.26 and then to RMB 37.28 [2][3][4]. - The estimated number of shares to be repurchased ranges from approximately 3,076,923 shares (0.77% of total shares) to 643,780 shares (1.61% of total shares) based on the maximum buyback amount [2][3]. Implementation Status - As of July 18, 2025, the company has repurchased a total of 4,265,977 shares, representing 1.07% of the total share capital, with a total transaction amount of approximately RMB 121.89 million [3][4]. - The highest transaction price during the buyback was RMB 30.07 per share, and the lowest was RMB 27.72 per share, with an average price of RMB 28.57 per share [3]. Share Cancellation - The company completed the cancellation of the repurchased shares on July 25, 2025, reducing the total share capital from 400,010,000 shares to 395,744,023 shares [3][4]. - The cancellation of shares will not significantly impact the company's operations, finances, or future development [4]. Share Structure Changes - Following the cancellation, the proportion of restricted shares increased from 78.49% to 79.34%, while the proportion of unrestricted shares decreased from 21.51% to 20.66% [4].

Group 1 - The company held its 10th meeting of the second Supervisory Board on July 28, 2025, with all three supervisors present, and the meeting was deemed legally valid [1][2] - The Supervisory Board approved the proposal for the capital reserve fund to increase share capital for the year 2024, considering the company's operational status, future development needs, and shareholder returns [1][2] - The proposal will be submitted for review at the company's second extraordinary general meeting of shareholders in 2025 [2] Group 2 - The meeting was convened by the chairman of the Supervisory Board, Mr. Luo Zhenbiao, and included the company’s board secretary, Mr. Deng Yonghui, as an attendee [1] - The decision made by the Supervisory Board was unanimous, with 3 votes in favor and no votes against or abstentions [2] - The company ensures that the information disclosed is true, accurate, and complete, with no misleading statements or significant omissions [1]

Meeting Information - The company will hold its second extraordinary general meeting of shareholders for 2025 on August 13, 2025, at 14:50 [1] - The meeting will utilize the Shenzhen Stock Exchange's online voting system for shareholder participation [1][2] Voting Procedures - Shareholders can vote either in person or through a proxy with a valid authorization letter [2] - The online voting will be available from 9:15 to 15:00 on August 13, 2025 [1][2] - Each voting right can only be exercised through one method: in-person, trading system, or internet voting [2] Attendance Requirements - Individual shareholders must present valid identification and proof of shareholding [4] - Corporate shareholders must provide documentation including a power of attorney if represented by an agent [4] Agenda Items - The meeting will discuss non-cumulative voting proposals, including a proposal for the capital reserve fund to increase share capital for the year 2024 [3][9]

证券代码：001323 证券简称：慕思股份 公告编号：2025-043 慕思健康睡眠股份有限公司 关于回购股份注销完成暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 （二）截至 2025 年 7 月 18 日，公司通过回购专用证券账户以集中竞价交易 的方式回购公司股份累计 4,265,977 股，占公司目前总股本的 1.07%，最高成交 价为 30.07 元/股，最低成交价为 27.72 元/股，成交均价为 28.57 元/股，成交总 金额为 121,890,087.10 元（不含交易费用），回购金额不低于回购方案中的回购 资金总额下限，且未超过回购资金总额上限。公司本次回购方案已实施完毕，实 施情况符合相关法律法规及公司回购股份方案的要求。公司实际回购股份时间区 间为 2024 年 7 月 23 日至 2025 年 4 月 30 日。具体内容详见 2025 年 7 月 22 日刊 登在《证券时报》《证券日报》《中国证券报》《上海证券报》及巨潮资讯网 （http://www.cninfo.com.cn）的《关于回购股份实施结果暨股份变动的公告 ...

证券代码：001323 证券简称：慕思股份 公告编号：2025-047 慕思健康睡眠股份有限公司 关于召开公司 2025 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要提示 股东大会召开日期：2025 年 8 月 13 日 本次股东大会采用的网络投票系统：深圳证券交易所股东会网络投票系 统 根据《中华人民共和国公司法》及《公司章程》的有关规定，经慕思健康睡 眠股份有限公司（以下简称"公司"或"本公司"）第二届董事会第十五次会议 审议通过，决定于 2025 年 8 月 13 日（星期三）下午 14:50 召开公司 2025 年第 二次临时股东大会，现将本次股东大会的有关事项通知如下： 一、召开会议的基本情况 1．会议届次：2025 年第二次临时股东大会 2、会议召集人：公司董事会 3、会议召开的合法、合规性：公司第二届董事会第十五次会议审议通过了 《关于提请召开 2025 年第二次临时股东大会的议案》。本次股东大会会议召集、 召开符合有关法律、行政法规、部门规章、规范性文件以及公司章程的规定。 4、会议召开的日期和时间： 其中， ...

证券代码：001323 证券简称：慕思股份 公告编号：2025-045 经各位监事认真审议，会议形成了如下决议： （一）审议通过《关于公司 2024 年度资本公积金转增股本预案的议案》 经审核，监事会认为：公司 2024 年度资本公积金转增股本预案符合相关法 律、法规、规范性文件以及《公司章程》的规定，充分考虑了公司目前的总体运 营情况、未来发展需求以及股东投资回报等因素，有利于公司的健康、稳定、可 持续发展，不存在损害公司及股东，特别是中小股东利益的情形。因此，同意将 该议案提交公司股东大会审议。 慕思健康睡眠股份有限公司 表决结果：3 票同意，0 票反对，0 票弃权。 第二届监事会第十次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 慕思健康睡眠股份有限公司（以下简称"公司"）第二届监事会第十次会议 由监事会主席罗振彪先生召集，会议通知于 2025 年 7 月 23 日以邮件、微信、电 话的方式送达全体监事，并于 2025 年 7 月 28 日上午 10:30 以现场及通讯会议方 式在公司会议室召开。本次会议应出席监事 ...

证券代码：001323 证券简称：慕思股份 公告编号：2025-044 慕思健康睡眠股份有限公司 第二届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 经与会各位董事认真审议，会议形成了如下决议： （一）审议通过《关于公司 2024 年度资本公积金转增股本预案的议案》 经致同会计师事务所（特殊普通合伙）审计，公司 2024 年度合并报表实现 归 属 上 市 公 司 股 东 的 净 利 润 767,327,852.54 元 ， 母 公 司 实 现 净 利 润 1,190,165,453.49 元。截至 2024 年 12 月 31 日，合并报表可供股东分配的利润为 1,386,257,322.06 元，母公司可供股东分配的利润为 1,316,881,104.32 元。合并报 表公司资本公积金余额为 2,790,812,746.15 元，其中，"资本公积-股本溢价"余 额为 2,761,455,190.94 元；母公司资本公积金余额为 2,677,113,438.92 元，其中， "资本公积-股本溢价"余额为 2 ...

证券代码：001323 证券简称：慕思股份 公告编号：2025-046 慕思健康睡眠股份有限公司 关于 2024 年度资本公积金转增股本预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、审议程序 慕思健康睡眠股份有限公司（以下简称"公司"）于 2025 年 7 月 28 日召开 第二届董事会第十五次会议、第二届监事会第十次会议，审议通过了《关于公司 2024 年度资本公积金转增股本预案的议案》，该议案尚需提交股东大会审议。 现将具体情况公告如下： 若公司在本次资本公积金转增股本预案披露后至权益分派实施期间因股权 激励行权、可转债转股、股份回购、新增股份上市等致使公司总股本发生变动的， 将按照转增比例不变的原则（即维持每 10 股转增 1 股的比例），相应调整转增 总额。 二、2024 年度资本公积金转增股本预案基本情况 1、分配基准：2024 年度。 2、经致同会计师事务所（特殊普通合伙）审计，公司 2024 年度合并报表实 现归属上市公司股东的净利润 767,327,852.54 元，母公司实现净利润 1,190,165,453.49 元。截至 ...

Group 1: Institutional Research on Popular Companies - The top twenty companies with the highest number of institutional research in the past 30 days include Ice Wheel Environment, China National Heavy Duty Truck Group, Boshi Jie, Yapu Co., and Huasheng Lithium Battery [13][14] - In the last five days, the most researched companies were Huasheng Lithium Battery, Weili Transmission, Hudian Co., Zhejiang Fu Holdings, and China National Heavy Duty Truck Group [13][15] - Among the top twenty companies researched in the past 30 days, seven had ten or more rating agencies, including Yanjing Beer, Hudian Co., Weichai Power, China National Heavy Duty Truck Group, BOE Technology Group, Hualing Steel, and Northern Rare Earth [13][14] - Yanjing Beer, Hudian Co., and BOE Technology Group are expected to see significant growth in net profit attributable to shareholders in 2024 compared to 2023 [13][14] Group 2: Shareholder Increase in A-Share Listed Companies - From July 21 to July 25, 2025, no companies reported significant shareholder increase announcements [16] - From January 1 to July 25, 2025, a total of 241 companies announced shareholder increases, with 63 having ten or more rating agencies [17] - Among these, 21 companies had an average proposed increase amount exceeding 1% of the latest market value, including Xianhe Co., Hubei Yihua, Xinji Energy, and Sailun Tire [17][18] Group 3: A-Share Buyback Situation - From July 21 to July 25, 2025, a total of 101 companies announced buyback progress, with 18 having ten or more rating agencies [21] - Four companies, including Jian Sheng Group, Mousse Co., Jinfa Technology, and Jinzai Food, had an average expected buyback amount exceeding 1% of the market value on the announcement date [21][22] - From January 1 to July 25, 2025, 1,605 companies announced buyback progress, with 348 having ten or more rating agencies [23] - Among these, 97 companies had a significant buyback ratio, with an average expected buyback amount exceeding 1% of the market value on the announcement date [23][24]